Pfizer - 47 Year Stock Price History | PFE

Historical daily share price chart and data for Pfizer since 1972 adjusted for splits. The latest closing stock price for Pfizer as of April 18, 2019 is 39.38.
  • The all-time high Pfizer stock price is 45.84, which is 16.4% above the current share price.
  • The Pfizer 52-week high stock price is 45.84, which is 16.4% above the current share price.
  • The Pfizer 52-week low stock price is 33.59, which is 14.7% below the current share price.
  • The average Pfizer stock price for the last 52 weeks is 40.43.
Pfizer Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 42.0941 42.8863 43.3600 39.1976 39.3800 -9.02%
2018 38.2492 34.8870 45.8412 32.4940 43.2829 24.82%
2017 32.0655 30.4028 35.6146 28.6984 34.6764 15.88%
2016 29.7281 28.3526 33.7464 25.6006 29.9238 4.46%
2015 29.4620 26.9004 31.5719 26.7545 28.6454 7.10%
2014 25.6040 25.2582 27.5530 23.5796 26.7459 5.30%
2013 23.6859 20.7898 26.7010 20.7416 25.3991 26.22%
2012 18.3054 16.9671 20.7017 16.3464 20.1232 20.41%
2011 14.7937 13.1043 16.8590 12.7394 16.7123 28.77%
2010 12.1856 13.4640 14.2250 10.2607 12.9783 0.31%
2009 10.9806 12.3287 13.4071 8.0411 12.9377 8.26%
2008 12.5938 14.4871 15.2270 9.7510 11.9508 -16.85%
2007 15.6106 15.8839 17.0871 14.1014 14.3733 -8.15%
2006 15.2528 13.8495 17.0473 13.2966 15.6482 15.22%
2005 14.6524 14.9461 16.5674 11.9975 13.5816 -10.62%
2004 18.4185 19.6789 21.5056 13.7255 15.1947 -22.31%
2003 17.5067 17.1288 19.8410 15.5918 19.5571 17.76%
2002 18.7816 21.3614 22.5660 13.9704 16.6073 -22.16%
2001 22.2043 24.4473 24.4473 18.9499 21.3346 -12.49%
2000 21.9252 16.7469 25.8608 15.8013 24.3784 43.06%
1999 20.1564 21.4471 26.1116 16.5797 17.0410 -21.50%
1998 17.6721 13.0440 21.8986 12.7424 21.7075 68.94%
1997 9.6487 6.9676 13.4094 6.9676 12.8493 81.93%
1996 6.1840 5.2096 7.7011 5.0841 7.0629 33.96%
1995 4.0058 3.1117 5.5444 3.0552 5.2724 66.70%
1994 2.6356 2.7032 3.2190 2.1478 3.1629 15.31%
1993 2.5197 2.8022 2.9314 2.1047 2.7429 -2.28%
1992 2.8746 3.1886 3.2550 2.5372 2.8068 -11.97%
1991 2.2313 1.4871 3.2550 1.3852 3.1886 112.74%
1990 1.2501 1.2707 1.5127 1.0123 1.4988 20.49%
1989 1.1075 0.9976 1.3379 0.9442 1.2439 24.15%
1988 0.9124 0.8085 1.0169 0.8085 1.0019 29.21%
1987 1.0831 1.0222 1.2613 0.6923 0.7754 -22.90%
1986 0.9935 0.8244 1.1994 0.7749 1.0057 20.49%
1985 0.7623 0.6656 0.9192 0.6285 0.8347 19.82%
1984 0.5883 0.5957 0.6966 0.4946 0.6966 18.19%
1983 0.6354 0.5585 0.7378 0.5585 0.5894 3.80%
1982 0.4982 0.4328 0.6574 0.4142 0.5678 29.34%
1981 0.4056 0.4390 0.4513 0.3359 0.4390 0.00%
1980 0.3424 0.3091 0.4390 0.2690 0.4390 35.29%
1979 0.2749 0.2730 0.3359 0.2411 0.3245 18.86%
1978 0.2618 0.2256 0.3164 0.2102 0.2730 21.01%
1977 0.2203 0.2370 0.2370 0.1937 0.2256 -6.43%
1976 0.2328 0.2340 0.2576 0.2102 0.2411 4.92%
1975 0.2463 0.2648 0.3009 0.1978 0.2298 -14.57%
1974 0.2733 0.3565 0.3637 0.1782 0.2690 -24.54%
1973 0.3617 0.3596 0.4318 0.3205 0.3565 0.85%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $237.400B $53.647B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $371.636B 16.85
Merck (MRK) United States $199.302B 17.03
Novartis AG (NVS) Switzerland $178.563B 15.19
Eli Lilly (LLY) United States $120.673B 20.95
Novo Nordisk (NVO) Denmark $118.536B 19.17
AbbVie (ABBV) United States $115.027B 9.86
Sanofi (SNY) France $103.057B 12.72
GlaxoSmithKline (GSK) United Kingdom $99.174B 13.02
AstraZeneca (AZN) United Kingdom $98.200B 11.20
Bristol-Myers Squibb (BMY) United States $74.835B 11.51